Collectively, these data demonstrate a novel MSI2 translocation-driven downstream event that leads to a more energetic, differentiation-arrested aggressive state, thus triggering CML progression to bcCML. Here, MSI2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.